Status Epilepticus in a Pediatric Patient With Amantadine Overdose

Pediatric Neurology

Volumn 40, Issue 2, 2009, Pages 120-122

  Claudet, Isabelle ^a   Maréchal, Céline ^a  

^a HÔPITAL DES ENFANTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CLONAZEPAM; DIAZEPAM; PHENYTOIN;

AGITATION; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CONTINUOUS INFUSION; DIAPHORESIS; DRUG OVERDOSE; EMERGENCY WARD; EPILEPTIC STATE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HOSPITAL DISCHARGE; HUMAN; INTOXICATION; MALE; MYDRIASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SINUS TACHYCARDIA; TONIC CLONIC SEIZURE; VOMITING;

AMANTADINE; CHILD, PRESCHOOL; DOPAMINE AGENTS; HUMANS; MALE; MYDRIASIS; OVERDOSE; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; STATUS EPILEPTICUS; TACHYCARDIA;

EID: 58149172195     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2008.10.011     Document Type: Article

References (22)

1. Davies W.L., Grunert R.R., Haff R.F., et al. Antiviral activity of 1-adamantanamine (amantadine). Science 144 (1964) 862-863
2. Scholtissek C., and Webster R.G. Long-term stability of the anti-influenza A compounds: amantadine and rimantadine. Antiviral Res 38 (1998) 213-215
3. Immunization Practices Advisory Committee. Centers for Disease Control, U.S. Department of Health and Human Services. Recommendations for prevention and control of influenza. Ann Intern Med 105 (1986) 399-404
4. Snoey E.R., and Bessen H.A. Acute psychosis after amantadine overdose. Ann Emerg Med 19 (1990) 668-670
5. Weller M., Finiels-Marlier F., and Paul S.M. NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine. Brain Res 613 (1993) 143-148
6. Green L.B., Hornyak J.E., and Hurvitz E.A. Amantadine in pediatric patients with traumatic brain injury: a retrospective, case-controlled study. Am J Phys Med Rehabil 83 (2004) 893-897
7. Wang R., and Zhang D. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model. Eur J Neurosci 22 (2005) 2376-2380
8. Chen H.S., and Lipton S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97 (2006) 1611-1626
9. Patrick P.D., Blackman J.A., Mabry J.L., Buck M.L., Gurka M.J., and Conaway M.R. Dopamine agonist therapy in low-response children following traumatic brain injury. J Child Neurol 21 (2006) 879-885
10. Reisberg B., Doody R., Stöffler A., Schmitt F., Ferris S., and Möbius H.J. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol 63 (2006) 49-54
11. Strong D.K., Eisenstat D.D., Bryson S.M., Sitar D.S., and Arbus G.S. Amantadine neurotoxicity in a pediatric patient with renal insufficiency. DICP 25 (1991) 1175-1177
12. Sartori M., Pratt C.M., and Young J.B. Torsade de pointe: malignant cardiac arrhythmia induced by amantadine poisoning. Am J Med 77 (1984) 388-391
13. Pimentel L., and Hughes B. Amantadine toxicity presenting with complex ventricular ectopy and hallucinations. Pediatr Emerg Care 7 (1991) 89-92
14. Cheng P.L., Hung S.W., Lin L.W., Chong C.F., and Lau C.I. Amantadine-induced serotonin syndrome in a patient with renal failure. Am J Emerg Med 26 (2008) 112.e5-6
15. Ito T., Shibata K., Watanabe A., and Akabane J. Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy. Eur J Pediatr 160 (2001) 401
16. Hartshorne N.J., Harruff R.C., and Logan B.K. Unexpected amantadine intoxication in the death of a trauma patient. Am J Forensic Med Pathol 16 (1995) 340-343
17. Simpson D.M., Ramos F., and Ramirez L.F. Death of a psychiatric patient from amantadine poisoning. Am J Psychiatry 145 (1988) 267-268
18. Bronstein A.C., Spyker D.A., Cantilena Jr. L.R., Green J., Rumack B.H., and Heard S.E. 2006 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol (Phila) 45 (2007) 815-917
19. Berkowitz C.D. Treatment of acute amantadine toxicity with physostigmine. J Pediatr 95 (1979) 144-145
20. Miller K.S., and Miller J.M. Toxic effects of amantadine in patients with renal failure. Chest 105 (1994) 1630
21. Hayes B.B., Cook-Norris R.H., Miller J.L., Rodriguez A., and Zic J.A. Amantadine-induced livedo reticularis: a report of two cases. J Drugs Dermatol 5 (2006) 288-289
22. Casey D.E. Amantadine intoxication reversed by physostigmine. N Engl J Med 298 (1978) 516